Internal Medicine, Hematology & Oncology · Sioux Falls, SD
NPI
1750357299
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 E. 23rd St., Ste. 230
Sioux Falls, SD, 57105
Phone (605) 322-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
2,544 services
Medicare patients, 2024
578
Average age 75
Drug cost, 2024
$10.4M
2,736 prescriptions
Company payments, 2025
$67.2
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark R Huber was code 99214 (office e&m - established), 561 times for 210 patients. In total Mark R Huber billed 2,544 services in 17 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 561 | 210 | $67.49 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 524 | 237 | $12.33 | $6,459 |
| 99214 Office E&M - Established | Office | 471 | 189 | $64.97 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 435 | 197 | $12.13 | $5,278 |
| 99213 Office E&M - Established | Facility | 90 | 75 | $41.84 | $3,766 |
| 99213 Office E&M - Established | Office | 79 | 58 | $41.38 | $3,269 |
| 99215 Office E&M - Established | Facility | 78 | 41 | $105.96 | $8,265 |
| 99232 Hospital E&M - Subsequent | Facility | 68 | 35 | $57.92 | $3,938 |
| 99222 Hospital E&M - Initial | Facility | 59 | 55 | $92.56 | $5,461 |
| 99215 Office E&M - Established | Office | 50 | 37 | $100.40 | $5,020 |
| 99205 Office E&M - New | Facility | 32 | 32 | $131.09 | $4,195 |
| 99204 Office E&M - New | Office | 27 | 27 | $92.75 | $2,504 |
| 99204 Office E&M - New | Facility | 20 | 20 | $99.57 | $1,991 |
| 99205 Office E&M - New | Office | 14 | 14 | $130.50 | $1,827 |
By year: 2022 $122K for 1,807 services; 2023 $124K for 1,918 services; 2024 $122K for 2,544 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark R Huber prescribed most often to Medicare patients was Levothyroxine Sodium, with 151 prescriptions and refills. In total Mark R Huber wrote 2,736 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 151 | 342 | 47 | $1,516 |
| Prednisone Generic | 141 | 194 | 54 | $615 |
| Acyclovir Generic | 135 | 304 | 41 | $2,405 |
| Ondansetron Hcl Generic | 125 | 127 | 59 | $1,132 |
| Brukinsa Zanubrutinib | 120 | 120 | 14 | $1.6M |
| Prochlorperazine Maleate Generic | 98 | 99 | 67 | $1,102 |
| Xtandi Enzalutamide | 81 | 81 | Under 11 | $1.0M |
| Hydroxyurea Generic | 79 | 171 | 16 | $1,708 |
| Eliquis Apixaban | 76 | 103 | 21 | $57K |
| Potassium Chloride Generic | 69 | 100 | 22 | $1,443 |
| Dexamethasone Generic | 69 | 75 | 34 | $878 |
| Anastrozole Generic | 65 | 164 | 21 | $1,290 |
| Olanzapine Generic | 62 | 73 | 25 | $635 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 56 | 56 | 26 | $2,217 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 51 | 51 | 38 | $572 |
Brand drugs: 846 claims; generic drugs: 1,890 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark R Huber $67.2 ($67.2 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $67.2.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $67.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.